913 USING SHORT-TERM MONOTHERAPY AND IN VITRO DATA TO MAKE EARLY PREDICTIONS OF CLINICAL HCV RESPONSE: EXAMPLES FROM MK-5172, A SECOND GENERATION HCV NS3/4A PROTEASE INHIBITOR
Nachbar, R.B, Stone, J.A, Petry, A, Poland, B, Caro, L, Wenning, L.A, Khan, A, Palcza, J, Van Dyck, K, Fraser, I, Mobashery, N, O'Mara, E
Published in Journal of hepatology (01.04.2012)
Published in Journal of hepatology (01.04.2012)
Get full text
Journal Article
Determination of the HIV integrase inhibitor, MK-0518 (raltegravir), in human plasma using 96-well liquid–liquid extraction and HPLC-MS/MS
Merschman, S.A., Vallano, P.T., Wenning, L.A., Matuszewski, B.K., Woolf, E.J.
Published in Journal of chromatography. B, Analytical technologies in the biomedical and life sciences (15.09.2007)
Published in Journal of chromatography. B, Analytical technologies in the biomedical and life sciences (15.09.2007)
Get full text
Journal Article